Publications by authors named "Barry Schlech"

Claim this Profile
B
Biocide uptake in contact lenses and loss of fungicidal activity during storage of contact lenses.
Ruth A Rosenthal, Nissanke L Dassanayake, Ronald L Schlitzer, Barry A Schlech, David L Meadows

Eye Contact Lens· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the preserving efficacy of lubricant eye drops with a novel preservative system.
Ruth A Rosenthal, Sally L Buck, Cindy L Henry, Barry A Schlech

J Ocul Pharmacol Ther· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone.
David W Stroman, Joseph J Dajcs, Gale A Cupp, Barry A Schlech

Surv Ophthalmol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans.
Stella M Robertson, Michael A Curtis, Barry A Schlech, Andrew Rusinko, Geoffrey R Owen

Surv Ophthalmol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Future of ophthalmic anti-infective therapy and the role of moxifloxacin ophthalmic solution 0.5% (VIGAMOX).
Barry A Schlech, Joseph Blondeau

Surv Ophthalmol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview of the potency of moxifloxacin ophthalmic solution 0.5% (VIGAMOX).
Barry A Schlech, Eduardo Alfonso

Surv Ophthalmol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amoebicidal activity of multipurpose contact lens solutions.
Sally L Buck, Ruth A Rosenthal, Barry A Schlech

Eye Contact Lens· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of regimen steps to disinfection of hydrophilic contact lenses.
Ruth A Rosenthal, Cindy L Henry, Barry A Schlech

Cont Lens Anterior Eye· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of myristamidopropyl dimethylamine (Aldox) against corneal isolates of Acanthamoeba spp.
Frederick L Schuster, Sally Buck, Ruth A Rosenthal, Barry A Schlech

J Eukaryot Microbiol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis and treatment.
Robert Abshire, Paul Cockrum, Julie Crider, Barry Schlech

Clin Ther· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and epidemiological advantages of culturing bacterial keratitis.
Kirk R Wilhelmus, Barry A Schlech

Cornea· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of fluoroquinolone susceptibility on the therapeutic response of fluoroquinolone-treated bacterial keratitis.
Kirk R Wilhelmus, Robert L Abshire, Barry A Schlech

Arch Ophthalmol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anatomy of a regimen: consideration of multipurpose solutions during non-compliant use.
Ruth A Rosenthal, Cindy L Henry, Ralph P Stone, Barry A Schlech

Cont Lens Anterior Eye· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of standard for evaluating the effectiveness of contact lens disinfectants.
Ruth A Rosenthal, Scott V W Sutton, Barry A Schlech

PDA J Pharm Sci Technol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis